12:00 AM
 | 
Jan 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

PolyTherics, Warwick Effect deal

PolyTherics acquired fellow drug delivery company Warwick Effect in an undisclosed stock deal. PolyTherics' gains Warwick Effect's PolyPEG and GlycoPol biopolymer technologies, for which...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >